GOLDMAN SACHS GROUP INC - UNUM THERAPEUTICS INC ownership

UNUM THERAPEUTICS INC's ticker is UMRX and the CUSIP is 903214104. A total of 1 filers reported holding UNUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of UNUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$76,000
+300.0%
32,500
-22.1%
0.00%
Q2 2020$19,000
+11.8%
41,7180.0%0.00%
Q1 2020$17,000
-48.5%
41,718
-10.0%
0.00%
Q4 2019$33,000
-77.9%
46,336
-55.2%
0.00%
Q3 2019$149,000
-2.6%
103,496
+76.7%
0.00%
Q2 2019$153,000
+118.6%
58,587
+267.8%
0.00%
Q1 2019$70,000
-25.5%
15,931
-25.6%
0.00%
Q4 2018$94,000
-27.7%
21,422
+70.0%
0.00%
Q3 2018$130,000
-71.4%
12,603
-60.2%
0.00%
Q2 2018$454,000
-24.1%
31,645
-41.2%
0.00%
Q1 2018$598,00053,7970.00%
Other shareholders
UNUM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 3,361,535$14,757,00013.86%
New Leaf Venture Partners, L.L.C. 1,795,545$7,882,0002.16%
SECTORAL ASSET MANAGEMENT INC 1,587,437$6,969,0000.84%
SABBY MANAGEMENT, LLC 206,358$906,0000.44%
COWEN INC. 817,395$3,588,0000.38%
Novo Holdings A/S 473,441$2,078,0000.31%
PLATINUM INVESTMENT MANAGEMENT LTD 260,595$1,144,0000.03%
WASATCH ADVISORS LP 254,449$1,117,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 109,075$479,0000.01%
FIL Ltd 783,423$3,439,0000.01%
View complete list of UNUM THERAPEUTICS INC shareholders